Literature DB >> 29234196

Glycochenodeoxycholic Acid Does Not Increase Transforming Growth Factor-Beta Expression in Bile Duct Epithelial Cells or Collagen Synthesis in Myofibroblasts.

Anna Wang1, Dorothy Yu2, Yuewen Gong1, Jessie Garber2, Gerald Y Minuk2,3.   

Abstract

BACKGROUND/AIMS: Primary sclerosing cholangitis (PSC) is a chronic, progressive hepatobiliary disorder characterized by extensive fibrosis and stricturing of the intra- and/or extra-hepatic bile ducts: Previous studies have documented low phosphatylcholine (PC) concentrations in PSC bile. The aim of this study was to determine whether low PC levels in bile facilitate toxic bile acid induced injury of biliary tract epithelial cells resulting in enhanced transforming growth factor-beta (TGF-β) expression and increased collagen synthesis by myofibroblasts.
METHODS: TGF-β mRNA expression was documented in bile duct epithelial cells exposed to varying concentrations of the toxic bile acid; glycochenodeoxycholic acid (GCDCA) ± PC.
RESULTS: In these experiments, as well as in co-culture experiments where bile duct epithelial cells were cultured with peripheral blood mononuclear cells and myofibroblasts, TGF-β mRNA expression remained unaltered in the presence or absence of PC. Moreover, collagen type Iα1 mRNA expression by myofibroblasts also remained unaltered.
CONCLUSION: The results of this study do not support the hypothesis that PC deficiency contributes to toxic bile acid-induced bile duct injury and/or myofibroblast activation.

Entities:  

Keywords:  DMEM, Dulbecco's modified Eagle medium; FBS, fetal bovine serum; GCDCA, glycochenodeoxycholic acid; PCR, Polymerase chain reaction; TGF-β, transforming growth factor-beta; bile acids; bile duct epithelial cells; fibrosis; phosphatylcholine; primary sclerosing cholangitis

Year:  2017        PMID: 29234196      PMCID: PMC5715442          DOI: 10.1016/j.jceh.2017.04.002

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  16 in total

1.  β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis.

Authors:  Ingo Strack; Sigrid Schulte; Heike Varnholt; Stephanie Schievenbusch; Ulrich Töx; Katharina Wendland; Hans-Michael Steffen; Uta Drebber; Hans-Peter Dienes; Margarete Odenthal
Journal:  Lab Invest       Date:  2010-10-04       Impact factor: 5.662

2.  Accumulation of macrophages in primary sclerosing cholangitis.

Authors:  R G Cameron; L M Blendis; M G Neuman
Journal:  Clin Biochem       Date:  2001-05       Impact factor: 3.281

Review 3.  TGF-β signaling in fibrosis.

Authors:  Anna Biernacka; Marcin Dobaczewski; Nikolaos G Frangogiannis
Journal:  Growth Factors       Date:  2011-07-11       Impact factor: 2.511

Review 4.  Primary sclerosing cholangitis.

Authors:  Y M Lee; M M Kaplan
Journal:  N Engl J Med       Date:  1995-04-06       Impact factor: 91.245

5.  Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer.

Authors:  Shahid A Khan; I Jane Cox; Andrew V Thillainayagam; Devinder S Bansi; Howard C Thomas; Simon D Taylor-Robinson
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-07       Impact factor: 2.566

Review 6.  MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes.

Authors:  Michael Trauner; Peter Fickert; Martin Wagner
Journal:  Semin Liver Dis       Date:  2007-02       Impact factor: 6.115

7.  Paclitaxel interrupts TGF-beta1 signaling between gallbladder epithelial cells and myofibroblasts.

Authors:  Ho-Soon Choi; Christopher E Savard; Jae-Woon Choi; Rahul Kuver; Sum P Lee
Journal:  J Surg Res       Date:  2007-06-14       Impact factor: 2.192

8.  Determination of individual serum bile acids in chronic liver diseases: fasting levels and results of oral chenodeoxycholic acid tolerance test.

Authors:  Y Adachi; T Nanno; T Itoh; Y Kurumi; K Yamazaki; Y Sawada; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1988-08

9.  Absence of glycochenodeoxycholic acid (GCDCA) in human bile is an indication of cholestasis: a 1H MRS study.

Authors:  Omkar B Ijare; Tedros Bezabeh; Nils Albiin; Urban Arnelo; Annika Bergquist; Bo Lindberg; Ian C P Smith
Journal:  NMR Biomed       Date:  2009-06       Impact factor: 4.044

10.  Role of phosphatidylcholine saturation in preventing bile salt toxicity to gastrointestinal epithelia and membranes.

Authors:  Elizabeth J Dial; Suzan H M Rooijakkers; Rebecca L Darling; Jim J Romero; Lenard M Lichtenberger
Journal:  J Gastroenterol Hepatol       Date:  2007-09-12       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.